HIF1A and chronic kidney disease: In CKD, HIFs especially HIF-1α accumulates in the ischemic tubulointerstitium28, therefore, the primary objective of this study was to pinpoint novel therapeutic modulators, which were associated with angiogenesis and activated by HIF-1α in the context of tubular hypoxia in RIF.